Meta-Analysis: Change in Albuminuria as a Surrogate Endpoint for Progression of Kidney Disease

24 Jan, 2019 | 15:49h | UTC

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials – The Lancet Endocrinology & Diabetes (link to abstract – $ for full-text)

Related Study: Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies – The Lancet Endocrinology & Diabetes (link to abstract – $ for full-text)

Commentaries: First Reports from Ambitious Workshop Published in The Lancet Diabetes and Endocrinology – National Kidney Foundation (free) AND Novel Albuminuria Endpoints May Improve CKD Progression Trials – Renal & Urology News (free)

 

Join our WhatsApp group

Free Updates in All Specialties!

A daily update on the latest medical news, practice-changing trials and guidelines

Stay Updated in Your Specialty
No spam, just news
Unsubscribe with one click

 

Daily

 

Weekly or Less Often 
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •